BCAX- Bicara Therapeutics Inc.

Name: Bicara Therapeutics Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Bicara Therapeutics Inc. (BCAX) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. BCAX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Mazumdar Claire	377.2K	$8.76M	-
COO	Cohlhepp Ryan	191.6K	$4.45M	-
CFO	Hyep Ivan	125.0K	$2.90M	-
Other	Meisner Lara	90.0K	$2.09M	-
Other	Raben David	60.8K	$1.41M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 15, 2026	Cohlhepp Ryan52	President And COO	Sale+OE	12,500	$20.29	$253,648.75	-3.1%	-	-
Apr 27, 2026	Raben David58	Chief Medical Officer	Sale+OE	5,500	$22.88	$125,830.10	-9.0%	-	-
Apr 20, 2026	Mazumdar Claire52	Chief Executive Officer	Sale+OE	15,000	$23.61	$354,145.50	-4.0%	-	-
Mar 25, 2026	Raben David58	Chief Medical Officer	Sale+OE	5,500	$18.95	$104,229.40	-9.0%	+24.4%	-
Mar 20, 2026	Mazumdar Claire52	Chief Executive Officer	Sale+OE	15,000	$18.82	$282,365.69	-1.5%	+26.2%	-
Mar 16, 2026	Cohlhepp Ryan52	President And COO	Sale+OE	12,500	$19.66	$245,713.75	-3.0%	+11.8%	-
Mar 9, 2026	Mazumdar Claire52	Chief Executive Officer	Sale+OE	36,766	$19.17	$704,657.16	-9.8%	+1.6%	-
Jan 15, 2026	Cohlhepp Ryan52	President And COO	Sell	149	$18.02	$2,684.98	-	+26.5%	-
Dec 22, 2025	Hyep Ivan62	Chief Financial Officer	Sale+OE	9,200	$18.31	$168,491.56	-6.0%	+0.4%	-
Dec 15, 2025	Cohlhepp Ryan52	President And COO	Sale+OE	12,500	$18.68	$233,547.50	-3.2%	+5.7%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC